Subclinical erectile dysfunction: Proposal for a novel taxonomic category in sexual medicine

Journal of Sexual Medicine

Volumn 3, Issue 5, 2006, Pages 787-794

  Jannini, Emmanuele A ^a   Lenzi, Andrea ^b   Isidori, Andrea ^b   Fabbri, Andrea ^c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Male erectile disorder; Oral vasoactive agents; Psychological assessment of sexual dysfunction

Indexed keywords

GONADORELIN; LUTEINIZING HORMONE; PHOSPHODIESTERASE V INHIBITOR; TESTOSTERONE;

BIOCHEMISTRY; DISEASE SEVERITY; DRUG DEPENDENCE; ERECTILE DYSFUNCTION; EVIDENCE BASED MEDICINE; HUMAN; IMPOTENCE; INCIDENCE; MALE SEXUAL DYSFUNCTION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; RISK ASSESSMENT; SEXOLOGY; SEXUAL BEHAVIOR; SEXUAL HEALTH; TAXONOMY;

EID: 33747697070     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2006.00287.x     Document Type: Article

References (49)

1. Cellerino A, Jannini EA. Male reproductive physiology as a sexually selected handicap? Erectile dysfunction is correlated with general health and health prognosis and may have evolved as a marker of poor phenotypic quality. Med Hypotheses 2005;65:179-84.
2. Cellerino A, Jannini EA. Why humans need type 5 phosphodiesterase inhibitors. Int J Androl 2005; 28 (Suppl. 2):14-7.
3. Frank E, Anderson C, Rubinstein D. Frequency of sexual dysfunction in 'normal' couples. N Engl J Med 1978;299:111-5.
4. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994;151:54-61.
5. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, Wang T. Sexual problems among women and men aged 40-80 y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005;17:39-57.
6. Moreira ED Jr, Brock G, Glasser DB, Nicolosi A, Laumann EO, Paik A, Wang T, Gingell C. Help-seeking behaviour for sexual problems: The global study of sexual attitudes and behaviors. Int J Clin Pract 2005;59:6-16.
7. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-30.
8. Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): A 5-year review of research and clinical experience. Int J Impot Res 2005;17:307-19.
9. Heruti R, Ashkenazi I, Shochat T, Tekes-Manova D, Justo D. Low scores in the sexual health inventory for men questionnaire may indicate sexual disorders other than erectile dysfunction. J Sex Med 2005;2:181-6.
10. de Boer BJ, Bots ML, Nijeholt AA, Moors JP, Verheij TJ. The prevalence of bother, acceptance, and need for help in men with erectile dysfunction. J Sex Med 2005;2:445-50.
11. NIH Consensus Development Panel on Impotence. NIH Consensus Conference. Impotence. JAMA 1993;270:83-90.
12. Sachs BD. Contextual approaches to the physiology and classification of erectile function, erectile dysfunction, and sexual arousal. Neurosci Biobehav Rev 2000;24:541-60.
13. Sachs BD. The false organic-psychogenic distinction and related problems in the classification of erectile dysfunction. Int J Impot Res 2003;15:72-8.
14. Carosa E, Benvenga S, Trimarchi F, Lenzi A, Pepe M, Simonelli C, Jannini EA. Sexual inactivity results in reversible reduction of LH bioavailability. Int J Impot Res 2002;14:93-9; discussion 100.
15. Corona G, Petrone L, Mannucci E, Mansani R, Balercia G, Krausz C, Giommi R, Forti G, Maggi M. Difficulties in achieving vs maintaining erection: Organic, psychogenic and relational determinants. Int J Impot Res 2005;17:252-8.
16. Anonymous. 1986 Subclinical hypothyroidism. Lancet 1986;1:251-2.
17. Hatzichristou D, Rosen RC, Broderick G, Clayton A, Cuzin B, Derogatis L, Litwin M, Meuleman E, O'Leary M, Quirk F, Sadovsky R, Seftel A. Clinical evaluation and management strategy for sexual dysfunction in men and women. J Sex Med 2004;1:49-57.
18. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998;338:1397-404.
19. Jannini EA, Lombardo F, Salacone P, Gandini L, Lenzi A. Treatment of sexual dysfunctions secondary to male infertility with sildenafil citrate. Fertil Steril 2004;81:705-7.
20. Lenzi A, Lombardo F, Salacone P, Gandini L, Jannini EA. Stress, sexual dysfunctions, and male infertility. J Endocrinol Invest 2003;26:72-6.
21. Jannini EALF, Salacone P, Gandini L, Lenzi A. Phosphodiesterase type 5 inhibitor therapy for sexual dysfunction induced in male infertility. Am J Urol Rev 2004;2:451-6.
22. Hart G, Wellings K. Sexual behaviour and its medicalisation: In sickness and in health. BMJ 2002;324:896-900.
23. Marcuse H. Eros and civilization. Boston, MA: Beacon Press; 1955.
24. Kahan SE, Seftel AD, Resnick MI. Sildenafil and the Internet. J Urol 2000;163:919-23.
25. Eysenbach G. Online prescribing of sildenafil (Viagra) on the World Wide Web. J Med Internet Res 1999;1:E10-1.
26. Athanasiadis L, Papaharitou S, Salpiggidis G, Tsimtsiou Z, Nakopoulou E, Kirana PS, Moisidis K, Hatzichristou D. Educating physicians to treat erectile dysfunction patients: Development and evaluation of a course on communication and management strategies. J Sex Med 2006;3:47-55.
27. Bancroft J. Central inhibition of sexual response in the male: A theoretical perspective. Neurosci Biobehav Rev 1999;23:763-84.
28. Fabbri A, Ulisse S, Jannini EA, Gnessi L, Moretti C, Isidori A. Opioid control of male reproductive system. In: Maggi M, Johnston CA, eds. Horizons in endocrinology. New York: Raven Press; 1989:301-6.
29. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 2002;53:865-71.
30. Di Luigi L, Guidetti L, Baldari C, Romanelli F. Heredity and pituitary response to exercise-related stress in trained men. Int J Sports Med 2003;24:551-8.
31. Granata A, Bancroft J, Del Rio G. Stress and the erectile response to intracavernosal prostaglandin E1 in men with erectile dysfunction. Psychosom Med 1995;57:336-44.
32. Dobson H, Smith RF. What is stress, and how does it affect reproduction? Anim Reprod Sci 2000;60-61:743-52.
33. Fabbri A, Jannini EA, Ulisse S, Gnessi L, Moretti C, Frajese G, Isidori A. Low serum bioactive luteinizing hormone in nonorganic male impotence: Possible relationship with altered gonadotropin-releasing hormone pulsatility. J Clin Endocrinol Metab 1988;67:867-75.
34. Jannini EA, Screponi E, Carosa E, Pepe M, Lo Giudice F, Trimarchi F, Benvenga S. Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone. Int J Androl 1999;22:385-92.
35. Carosa E, Martini P, Brandetti F, Di Stasi SM, Lombardo F, Lenzi A, Jannini EA. Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. Clin Endocrinol (Oxf) 2004;61:382-6.
36. Fabbri A, Jannini EA, Gnessi L, Ulisse S, Moretti C, Isidori A. Neuroendocrine control of male reproductive function. The opioid system as a model of control at multiple sites. J Steroid Biochem 1989;32:145-50.
37. Tilbrook AJ, Turner AI, Clarke IJ. Stress and reproduction: Central mechanisms and sex differences in non-rodent species. Stress 2002;5:83-100.
38. Aversa A, Isidori AM, De Martino MU, Caprio M, Fabbrini E, Rocchietti-March M, Frajese G, Fabbri A. Androgens and penile erection: Evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction. Clin Endocrinol (Oxf) 2000;53:517-22.
39. Aversa A, Isidori AM, Greco EA, Giannetta E, Gianfrilli D, Spera E, Fabbri A. Hormonal supplementation and erectile dysfunction. Eur Urol 2004;45:535-8.
40. Aversa A, Mazzilli F, Rossi T, Delfino M, Isidori AM, Fabbri A. Effects of sildenafil (Viagra) administration on seminal parameters and post-ejaculatory refractory time in normal males. Hum Reprod 2000;15:131-4.
41. Smith KM, Romanelli F. Recreational use and misuse of phosphodiesterase 5 inhibitors. J Am Pharm Assoc (Wash DC) 2005;45:63-72; quiz 73-65.
42. Aversa A, Pili M, Fabbri A, Spera E, Spera G. Erectile dysfunction: Expectations beyond phosphodiesterase type 5 inhibition. J Endocrinol Invest 2004;27:192-206.
43. Alpert JS. Viagra: The risks of recreational use. Am J Med 2005;118:569-70.
44. Althof SE. Erectile dysfunction. Psychotherapy with men and couples. In: Leiblum SR Rosen RC, eds. Principles and practice of sex therapy. New York: Guilford Press; 2000:242-75.
45. Deumie L. [Transfert, erotomania, delusional love during psychotherapy of psychoses]. Ann Med Psychol (Paris) 1981;139:356-62.
46. Monzani F, Caraccio N, Kozakowa M, Dardano A, Vittone F, Virdis A, Taddei S, Palombo C, Ferrannini E. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: A double-blind, placebo-controlled study. J Clin Endocrinol Metab 2004;89:2099-106.
47. Department of Reproductive Health, Research WHO. Sexual health - a new focus for WHO. Prog Reprod Health Res 2004;64:1-8.
48. Sadovsky R, Nusbaum M. Sexual health inquiry and support is a primary care priority. J Sex Med 2006;3:3-11.
49. Moynihan R. The making of a disease: Female sexual dysfunction. BMJ 2003;326:45-7.